Salts of N-[6-cis-2,6dimethylmorpholin-4yl)pyridine-3yl]-2methyl-4'- (trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide

Details for Australian Patent Application No. 2012203520 (hide)

Owner Novartis AG

Inventors Bajwa, Joginder Singh; De La Cruz, Marilyn; Dodd, Stephanie Kay; Waykole, Liladhae Murlidhar; Wu, Raeann

Agent Davies Collison Cave

Pub. Number AU-A-2012203520

Parent 2009293444

Filing date 15 June 2012

Wipo publication date 5 July 2012

International Classifications

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5377

A61K 35/00 Medicinal preparations containing material or reaction products thereof with undetermined constitution

Event Publications

28 June 2012 Complete Application Filed

5 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203520

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203521-Immobilized biologically active entities having a high degree of biological activity

2012203519-Treatment of cytokine mediated conditions